药品注册申请号:016269
申请类型:NDA (新药申请)
申请人:HOSPIRA
申请人全名:HOSPIRA INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 MANNITOL 5% MANNITOL INJECTABLE;INJECTION 5GM/100ML No No None 1967/12/22 Approved Prior to Jan 1, 1982 Discontinued
002 MANNITOL 10% MANNITOL INJECTABLE;INJECTION 10GM/100ML No No None Approved Prior to Jan 1, 1982 Discontinued
003 MANNITOL 15% MANNITOL INJECTABLE;INJECTION 15GM/100ML No No None Approved Prior to Jan 1, 1982 Discontinued
004 MANNITOL 20% MANNITOL INJECTABLE;INJECTION 20GM/100ML No No None Approved Prior to Jan 1, 1982 Discontinued
005 MANNITOL 25% MANNITOL INJECTABLE;INJECTION 12.5GM/50ML No No None Approved Prior to Jan 1, 1982 Discontinued
006 MANNITOL 25% MANNITOL INJECTABLE;INJECTION 12.5GM/50ML No No AP 1994/08/25 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2020/03/17 SUPPL-56(补充) Approval Efficacy STANDARD
2019/01/09 SUPPL-55(补充) Approval Labeling STANDARD
2015/10/08 SUPPL-52(补充) Approval Manufacturing (CMC) STANDARD
2015/04/08 SUPPL-51(补充) Approval Manufacturing (CMC) STANDARD
2002/11/18 SUPPL-43(补充) Approval Manufacturing (CMC) STANDARD
2002/09/05 SUPPL-41(补充) Approval Labeling
1997/01/17 SUPPL-40(补充) Approval Manufacturing (CMC) STANDARD
1996/08/27 SUPPL-38(补充) Approval Manufacturing (CMC) STANDARD
1995/08/14 SUPPL-39(补充) Approval Manufacturing (CMC) STANDARD
1994/08/25 SUPPL-37(补充) Approval Labeling
1991/06/04 SUPPL-36(补充) Approval Manufacturing (CMC) STANDARD
1988/02/01 SUPPL-35(补充) Approval Manufacturing (CMC) STANDARD
1985/11/22 SUPPL-33(补充) Approval Manufacturing (CMC) STANDARD
1983/07/05 SUPPL-32(补充) Approval Manufacturing (CMC) STANDARD
1982/10/04 SUPPL-28(补充) Approval Manufacturing (CMC) STANDARD
1982/06/17 SUPPL-27(补充) Approval Labeling
1982/05/05 SUPPL-31(补充) Approval Labeling
1981/09/01 SUPPL-30(补充) Approval Labeling
1981/02/02 SUPPL-29(补充) Approval Manufacturing (CMC) STANDARD
1981/01/13 SUPPL-26(补充) Approval Manufacturing (CMC) STANDARD
1980/10/02 SUPPL-24(补充) Approval Labeling
1980/09/25 SUPPL-25(补充) Approval Manufacturing (CMC) STANDARD
1980/09/03 SUPPL-23(补充) Approval Manufacturing (CMC) STANDARD
1980/07/22 SUPPL-18(补充) Approval Labeling
1980/07/22 SUPPL-17(补充) Approval Manufacturing (CMC) STANDARD
1980/06/10 SUPPL-22(补充) Approval Manufacturing (CMC) STANDARD
1980/06/06 SUPPL-21(补充) Approval Manufacturing (CMC) STANDARD
1980/05/27 SUPPL-20(补充) Approval Manufacturing (CMC) STANDARD
1980/01/08 SUPPL-19(补充) Approval Manufacturing (CMC) STANDARD
1978/09/07 SUPPL-14(补充) Approval Manufacturing (CMC) STANDARD
1978/08/18 SUPPL-16(补充) Approval Manufacturing (CMC) STANDARD
1977/12/02 SUPPL-15(补充) Approval Manufacturing (CMC) STANDARD
1977/02/04 SUPPL-13(补充) Approval Manufacturing (CMC) STANDARD
1976/03/01 SUPPL-12(补充) Approval Manufacturing (CMC) STANDARD
1967/12/22 ORIG-1(原始申请) Approval Type 5 - New Formulation or New Manufacturer STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:MANNITOL 剂型/给药途径:INJECTABLE;INJECTION 规格:12.5GM/50ML 治疗等效代码:AP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
080677 001 ANDA MANNITOL 25% MANNITOL INJECTABLE;INJECTION 12.5GM/50ML Prescription No No AP Approved Prior to Jan 1, 1982 FRESENIUS KABI USA
016269 006 NDA MANNITOL 25% MANNITOL INJECTABLE;INJECTION 12.5GM/50ML Prescription No No AP 1994/08/25 HOSPIRA
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database